Corcept Appoints Monica Tellado As President, Emerging Markets
Portfolio Pulse from Benzinga Newsdesk
Corcept Therapeutics Incorporated (NASDAQ:CORT) has appointed Monica Tellado as President, Emerging Markets. Tellado, who previously served as CFO at Heartflow and held various leadership roles at Gilead Sciences, will report to Corcept's CEO and join the company's Executive Team. She will serve as the global commercial lead for therapeutics in metabolism and neurology and oversee pipeline and portfolio planning activities across the company's other therapeutic areas.
November 01, 2023 | 12:17 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
The appointment of Monica Tellado as President, Emerging Markets at Corcept Therapeutics could potentially strengthen the company's leadership team and enhance its strategic planning and commercial operations, particularly in the areas of metabolism and neurology therapeutics.
Monica Tellado's extensive experience in commercial planning and product launches, as well as her previous leadership roles at Heartflow and Gilead Sciences, could potentially enhance Corcept's strategic planning and commercial operations. This could lead to improved product launches and potentially higher revenues, which could positively impact the company's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100